Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25932466 | 0.91 | ALOX15 (0.32) | ALDH1A1ALOX15 | |
| SCHEMBL9480850 | 0.88 | ALDH1A1 (0.40) | ALDH1A1ATMNAAA | |
| SCHEMBL17212387 | 0.83 | SMN1; SMN2 (0.35) | ALDH1A1HCAR2 | |
| SCHEMBL7224938 | 0.82 | ALDH1A1 (0.54) | ALDH1A1HCAR2ATMNAAA | |
| SCHEMBL17403977 | 0.82 | ALDH1A1 (0.54) | ALDH1A1HCAR2ATMNAAA | |
| SCHEMBL25928819 | 0.81 | ALOX15 (0.32) | ALOX15 | |
| SCHEMBL27982814 | 0.80 | NAAA (0.44) | ALDH1A1HCAR2NAAA | |
| SCHEMBL8421539 | 0.80 | NAAA (0.44) | ALDH1A1HCAR2NAAA | |
| SCHEMBL7224840 | 0.80 | NAAA (0.52) | ALDH1A1HCAR2ATMNAAA | |
| SCHEMBL20747281 | 0.80 | CYP1A2 (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702404-B2 | GLP-1R modulating compounds | GILEAD SCIENCES, INC. (US) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702404-B2 | GLP-1R modulating compounds | GLP1R, GIPR, GPR119 | ALDH1A1 3556/4885HCAR2 483/4885ATM 4056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.